News
Behind the scenes, the FDA’s Elsa tool scans safety reports, identifies label inconsistencies, and helps staff prioritize inspections. If it works as intended, this quiet efficiency could ...
The U.S. Food and Drug Administration (FDA) has introduced “Elsa,” a generative AI tool designed to enhance the efficiency of its regulatory operations. Elsa's deployment comes nearly a month ...
FDA Chief AI Officer Jeremy Walsh described the release of Elsa as the dawn of the AI era at the FDA. The tool is expected to enhance and optimize the performance and potential of every employee.
The U.S. Food and Drug Administration (“FDA”) has fast-tracked the rollout of its AI tool, Elsa, originally planned for June 30, with Commissioner Dr Tuesday, 02 January 2024 12:17 GMT عربي ...
The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews.
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. The FDA plans to roll out its new AI tool, called Elsa ...
On June 2, 2025, FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to investigators—work more efficiently.” Per FDA, the tool ...
The FDA rolled out its agency-wide AI tool weeks ahead of schedule, on Monday offering a look at the technology and how it may be used.
FDA Chief AI Officer Jeremy Walsh described the release of Elsa as the dawn of the AI era at the FDA. The tool is expected to enhance and optimize the performance and potential of every employee. As ...
The U.S. Food and Drug Administration (“FDA”) has fast-tracked the rollout of its AI tool, Elsa, originally planned for June 30, with Commissioner Dr. Marty Makary touting the launch as both ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results